Bleeding Disorders in 2035: Michael Makris is Future-Focused at HABIT Summit 2025
Brian O Mahony, CEO of Irish Haemophilia Society, posted in appreciation of Michael Makris on X:
”Professor Michael Makris giving his view on bleeding disorders treatment and comprehensive care in year 2035 at HABIT Summit 2025 in Osaka, Japan.”
While most of us are still figuring out how to schedule next week’s clinic, Professor Michael Makris is already living in 2035.
At the HABIT Summit 2025 held in Osaka, Japan, Professor Makris, a leading voice in hematology, delivered an insightful presentation on the projected state of bleeding disorders care in the year 2035.
With decades of experience in clinical practice and policy, he offered a forward-looking perspective on how treatment, patient management, and comprehensive care models are expected to evolve over the next decade.
Read Hemostasis Today, to not miss out on important in the field of thrombosis and hemostasis.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis